Reports for MYLAN PHARMACEUTICALS ULC
Company Name
MYLAN PHARMACEUTICALS ULC
Totals |
||
Shortage reports |
650 |
|
| Actual shortage: | 13 (2%) | |
| Anticipated shortage: | 6 (1%) | |
| Avoided shortage: | 85 (13%) | |
| Resolved: | 546 (84%) | |
Discontinuation Reports |
234 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 234 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
82 (9%) |
|
Overdue reports |
0 (0%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION | Resolved | 2020-01-28 | 2020-02-12 | 104521 |
| MYLAN-MIRTAZAPINE | 45MG | TABLET | Resolved | 2020-01-28 | 2020-02-20 | 104515 |
| RIMSO-50 | 500MG | SOLUTION | Resolved | 2019-10-04 | 2020-02-20 | 95465 |
| MYLAN-ENALAPRIL | 2MG | TABLET | Resolved | 2018-07-04 | 2020-02-20 | 54212 |
| MYLAN-ENALAPRIL | 4MG | TABLET | Resolved | 2018-07-04 | 2020-02-20 | 54219 |
| MYLAN-ENALAPRIL | 16MG | TABLET | Resolved | 2018-07-04 | 2020-02-20 | 54242 |
| MYLAN-ENALAPRIL | 8MG | TABLET | Resolved | 2018-07-04 | 2020-02-20 | 54237 |
| MOVISSE | 0.35MG | TABLET | Resolved | 2020-01-29 | 2020-02-26 | 104691 |
| FREYA 28 | 0.15MG 0.03MG | TABLET | Resolved | 2020-02-12 | 2020-03-04 | 105774 |
| MYLAN-BUDESONIDE AQ | 64MCG | SPRAY, METERED DOSE | Resolved | 2017-09-22 | 2020-03-04 | 23169 |
| MYLAN-TADALAFIL | 20MG | TABLET | Resolved | 2019-09-19 | 2020-03-04 | 94402 |
| MYLAN-BUDESONIDE AQ | 100MCG | SPRAY, METERED DOSE | Resolved | 2020-02-04 | 2020-03-04 | 105234 |
| MYLAN-FINGOLIMOD | 0.5 mg | capsules | Resolved | 2019-12-19 | 2020-03-13 | 101762 |
| CLARUS | 10MG | CAPSULE | Resolved | 2019-10-29 | 2020-03-18 | 97440 |
| MYLAN-VERAPAMIL SR | 120MG | TABLET (EXTENDED-RELEASE) | Avoided shortage | 2020-01-23 | 2020-03-25 | 104079 |
| MYLAN-BECLO AQ | 50MCG | METERED-DOSE AEROSOL SUSPENSION | Resolved | 2019-10-15 | 2020-03-26 | 96537 |
| MYLAN-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-01-28 | 2020-03-26 | 104631 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION | Resolved | 2020-02-12 | 2020-04-02 | 105793 |
| PYRIDOXINE HYDROCHLORIDE INJECTION, USP | 100MG | SOLUTION | Resolved | 2019-10-01 | 2020-04-02 | 95091 |
| CLARUS | 40MG | CAPSULE | Resolved | 2020-03-18 | 2020-04-08 | 108871 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-RISPERIDONE ODT | 0.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149759 |
| MYLAN-RISPERIDONE ODT | 1MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149762 |
| MYLAN-RISPERIDONE ODT | 2MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149765 |
| MYLAN-RISPERIDONE ODT | 3MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149768 |
| MYLAN-RISPERIDONE ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149771 |
| TOBRAMYCIN INJECTION, USP | 40MG | SOLUTION | Discontinued | 2022-01-12 | 2022-01-12 | 152485 |
| MYLAN-TOLTERODINE ER | 2MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2022-02-15 | 2022-02-15 | 155037 |
| MYLAN-TOLTERODINE ER | 4MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2022-02-15 | 2022-02-15 | 155040 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION | Discontinued | 2022-05-11 | 2022-05-11 | 160323 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION SOLUTION | Discontinued | 2022-05-11 | 2022-05-11 | 160318 |
| MYLAN-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2022-08-25 | 2022-08-25 | 167806 |
| MYLAN-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2022-08-25 | 2022-08-25 | 167819 |
| MYLAN-VERAPAMIL | 80MG | TABLET | Discontinued | 2024-04-11 | 2024-04-12 | 224846 |
| MYLAN-NITRO SUBLINGUAL SPRAY | 0.4MG | METERED-DOSE AEROSOL | Discontinued | 2024-05-08 | 2024-05-08 | 227338 |